AI can help inform the personalized dose of radiation to treat cancer patients, with the technology using information from medical scans and EHRs, according to researchers from Cleveland Clinic.

Healthcare AI has been slow to gain a firm foothold across Europe for two reasons, according to a report published in Science|Business July 1.

Gadolinium-based contrast agents (GBCAs) can often bring out the best in MRI, but they’re controversial and thus increasingly avoided. A pilot study in Germany shows how an algorithm might substitute for an injection to track tumors of the brain and spinal cord (aka gliomas).

An Irish AI startup whose investors have already raised $65 million is pledging to deliver a breakthrough natural food additive by the end of this year and four more by 2021.

While Google has ventured into the healthcare field with various technologies and tools, it is also collecting vast amounts of healthcare data through these tools and through deals with healthcare stakeholders.

Aided by augmented reality, AI and portable neuroimaging technology, physicians may soon be able to tease out images of patients’ brains—right there in the doctor’s office—to see how much pain each patient is suffering.

Healthcare AI isn’t yet good enough to reliably deliver on its promises where it stands to make the biggest difference—and it doesn’t have enough high-quality data to get there anytime soon.

Only one-fifth of consumers would trust healthcare advice from AI-generated communications, according to a recent poll.

Hospital operating rooms hoping to keep up with their competition during a forecasted $2.5 billion spending spree need to invest in integrating robotics to improve precision, virtual reality to inform pre-surgery planning and AI to analyze risks.

Mount Sinai Health System, a New York-based hospital network, is working on a series of digital news segments with Discovery’s Science Channel to reveal innovations in science and medicine, including AI.